Sort
4,870 grants matching “glp 1”
Manufacturing of Trojan Horse-TNFR Decoy Receptor Fusion Protein
$589,542Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2014 · AG
Identifying a novel player in skeletal muscle performance and metabolism
$589,326Vishwajeet Puri · Ohio University Athens · R01 · FY2025 · DK
Neuroprotective And Neurorestorative Signaling Mechanisms
$589,281Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG
Role of colonic enteroendocrine cells in metabolic control
$589,159Ezra Burstein · Ut Southwestern Medical Center · R01 · FY2022 · DK
Reversing Isoniazid Resistance By Isotopic Substitution
$586,360Graham S Timmins · Spinceutica, Inc. · R44 · FY2017 · AI
Role of the Unfolded Protein Response in Beta Cell
$585,755Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R37 · FY2012 · DK
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$585,583Ana Krtolica · Omniox, Inc. · R01 · FY2018 · CA
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine
$585,257Jay Williams Hooper · Geneva Foundation · R01 · FY2014 · AI
Early Prediction of Tumor Response to Treatment: Clinical Translation of [99mTc]-Duramycin
$585,113Koon Y Pak · Molecular Targeting Technologies, Inc. · R01 · FY2019 · CA
Medicinal Chemistry Optimization of Anti-Alphaviral Leads and Elucidation of Target and Off Target Engagement
$583,618Jennifer E. Golden · University Of Tennessee Health Sci Ctr · U19 · FY2022 · AI
Metachromatic Leukodystrophy Enzyme Drug Development
$583,336Ka-Wai Hui · Armagen Technologies, Inc. · R44 · FY2014 · HD
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer
$583,071Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2023 · CA
Role of slowly digestible starch in diabetes risk factors in pre-diabetic people
$582,655Eric Ravussin · Lsu Pennington Biomedical Research Ctr · R01 · FY2015 · DK
Phase one clinical trial of a novel small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein- Barr positive nasopharyngeal cancer, with pharmacokinetic and pharmacodynamic correlative studies
$582,474A. Dimitrios Colevas · Stanford University · R01 · FY2023 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$582,405Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease
$581,422Deok-Ho Kim · Johns Hopkins University · R01 · FY2025 · NS
Enhancing Weight Loss Maintenance with GLP-1 in Adolescents with Severe Obesity
$581,312Aaron S Kelly · University Of Minnesota · R01 · FY2015 · DK
Early Screening of Breast Lesion Trial (Phase III Pivotal)
$581,183David A. Benaron · Spectros Corporation · R44 · FY2010 · CA
Adenosine-3 agonists for the suppression of arthritis
$581,080Inotek Pharmaceuticals Corporation · R44 · FY2003 · AR
Mechanisms of Glycemic Improvement Following Gastrointestinal Surgery
$580,913David R Flum · University Of Washington · R01 · FY2009 · DK
Commercialization Readiness Program (CRP) for Bioabsorbable Magnesium (Mg) Implants for Craniomaxillofacial Surgical Systems
$580,868Stephen Lebeau · Nanomag, Llc · R44 · FY2021 · DE
Targeting FSH for the Therapy of Osteoporosis, Obesity and Neurodegeneration
$580,384Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AG
Regulation of Body Composition and Energy Metabolism by LH With Aging
$580,383Daria Lizneva · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AG
Role of the Unfolded Protein Response in Beta Cell
$580,221Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R37 · FY2015 · DK
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
$579,607Venkatram Reddy Atigadda · University Of Alabama At Birmingham · R01 · FY2024 · CA